Cellectar Biosciences, Inc. (CLRB): Free Cash Flow
-$23.12M
Year ended 2025-12-31
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$23.12M | n/m | 2026-03-04, From 2025-01-01 |
| 2024-12-31 | -$47.69M | n/m | 2026-03-04, From 2024-01-01 |
| 2023-12-31 | -$33.24M | n/m | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | -$25.45M | n/m | 2024-10-29, From 2022-01-01 |
| 2021-12-31 | -$22.71M | n/m | 2023-03-09, From 2021-01-01 |
| 2020-12-31 | -$14.00M | n/m | 2022-03-21, From 2020-01-01 |
| 2019-12-31 | -$11.72M | n/m | 2021-03-02, From 2019-01-01 |
| 2018-12-31 | -$11.83M | n/m | 2020-03-09, From 2018-01-01 |
| 2017-12-31 | -$11.37M | n/m | 2019-02-26, From 2017-01-01 |
| 2016-12-31 | -$8.35M | n/m | 2018-03-21, From 2016-01-01 |
| 2015-12-31 | -$8.27M | n/m | 2017-03-15, From 2015-01-01 |
| 2014-12-31 | -$8.87M | n/m | 2016-10-20, From 2014-01-01 |
| 2013-12-31 | -$9.30M | n/m | 2015-05-20, From 2013-01-01 |
| 2012-12-31 | -$6.68M | n/m | 2014-03-19, From 2012-01-01 |
| 2011-12-31 | -$6.09M | n/m | 2013-03-28, From 2011-01-01 |
| 2010-12-31 | -$3.38M | n/a | 2012-03-09, From 2010-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Cellectar Biosciences, Inc. (CLRB) | 2025-12-31 | -$23.12M | n/m |
| Cingulate Inc. (CING) | 2025-12-31 | -$17.41M | n/m |
| Synlogic, Inc. (SYBX) | 2025-12-31 | -$4.36M | n/m |
| Aprea Therapeutics, Inc. (APRE) | 2024-12-31 | -$13.57M | n/m |
| Exicure, Inc. (XCUR) | 2025-12-31 | -$8.56M | n/m |
| Chemomab Therapeutics Ltd. (CMMB) | 2025-12-31 | -$11.13M | n/m |
| CalciMedica, Inc. (CALC) | 2025-12-31 | -$21.21M | n/m |
| Aditxt, Inc. (ADTX) | 2025-12-31 | -$25.70M | n/a |
| Tempest Therapeutics, Inc. (TPST) | 2025-12-31 | -$26.82M | n/m |
Compare CLRB, CING, SYBX, APRE side by side · Screen every company in Pharmaceutical Preparations ↗